Patents by Inventor Hans-Joachim Rziha

Hans-Joachim Rziha has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Production of recombinant expression vectors
    Patent number: 10655134
    Abstract: The present invention relates to a method for the production of recombinant expression vectors, a kit adapted to carrying out the method, a vector used in the context of the method, a cell containing such vector and the use of the vector.
    Type: Grant
    Filed: May 9, 2017
    Date of Patent: May 19, 2020
    Assignee: EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAETGESCHWISTER-SCHOLL-PLATZ
    Inventors: Ralf Amann, Hans-Joachim Rziha
  • RECOMBINANT ORF VIRUS VECTOR
    Publication number: 20180148739
    Abstract: A nucleic acid molecule can code for an Orf virus vector promoter. A recombinant Orf virus vector can be included in a cell. The nucleic acid molecule, the vector and/or the cell can be included in a composition. The recombinant Orf virus vector can be used for the production of a foreign gene.
    Type: Application
    Filed: January 19, 2018
    Publication date: May 31, 2018
    Inventors: Hans-Joachim Rziha, Ralf Amann
  • PRODUCTION OF RECOMBINANT EXPRESSION VECTORS
    Publication number: 20170240907
    Abstract: The present invention relates to a method for the production of recombinant expression vectors, a kit adapted to carrying out the method, a vector used in the context of the method, a cell containing such vector and the use of the vector.
    Type: Application
    Filed: May 9, 2017
    Publication date: August 24, 2017
    Applicant: Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet
    Inventors: Ralf AMANN, Hans-Joachim RZIHA
  • Parapoxviruses containing foreign DNA, their production and their use in vaccines
    Patent number: 6365393
    Abstract: The present invention relates to recombinantly prepared parapoxviruses which carry, in their genomes, deletions or insertions in the form of foreign hereditary information and contain hereditary information, to the preparation of such constructs and to their use in vaccines.
    Type: Grant
    Filed: August 20, 1998
    Date of Patent: April 2, 2002
    Assignee: Bayer Aktiengesellschaft
    Inventors: Norbert Schmeer, Walter Strube, Mathias Büttner, Hans-Joachim Rziha